Reduced thrombin binding and aggregation in Bernard-Soulier platelets

The Journal of Clinical Investigation
G A Jamieson, T Okumura

Abstract

Platelets from two patients with Bernard-Soulier disease showed a reduction in their ability to bind human thrombin. Thrombin binding studies in the high affinity range showed 1,500 sites for the Bernard-Soulier platelets as against 4,000 for normal controls. However, the dissociation constant was the same for both normals and patients (4.4 nM) indicating identical affinity for thrombin at the available sites. In the low affinity range, the Bernard-Soulier platelets showed 8,800 thrombin binding sites as against 24,000 for the controls, but again with identical values of Kd (37 nM). In addition, platelets from these Bernard-Soulier patients showed a decreased rate of aggregation with thrombin at both optimal (300 mU/ml) and suboptimal (60 and 120 mU/ml) thrombin concentrations. The decreased amount of thrombin which can bind to Bernard-Soulier platelets and the decrease in thrombin-induced aggregation may partly explain the hemostatic defect in these patients. In addition, the identical ratios of high affinity and low affinity binding sites in normals and in patients (0.37 and 0.36, and 0.36, respectively) supports the idea of a single class of binding sites for thrombin on the platelet surface.

References

Feb 22, 1977·Biochimica Et Biophysica Acta·E P Kang, D C Triantaphyllopoulos
May 18, 1976·Biochemistry·D M Tollefsen, P W Majerus
Nov 2, 1976·Biochemistry·B M MartinT C Detwiler
Oct 1, 1975·The Journal of Clinical Investigation·M A Shuman, P W Majerus
Jun 9, 1973·British Medical Journal·M A HowardR M Hardisty
Feb 1, 1974·Nature·P Ganguly
Mar 1, 1969·British Journal of Haematology·K A Gröttum, N O Solum
Mar 8, 1965·Biochimica Et Biophysica Acta·T L STECK, D F HOELZLWALLACH

❮ Previous
Next ❯

Citations

Jul 16, 1990·Biochemical and Biophysical Research Communications·G J RothS A Williams
Feb 24, 1988·Biochimica Et Biophysica Acta·K J Clemetson, E F Lüscher
Mar 18, 1981·Biochimica Et Biophysica Acta·S M JungG A Jamieson
Nov 28, 1993·Biochimica Et Biophysica Acta·T F HuangC M Teng
Nov 8, 2003·Trends in Molecular Medicine·Frédéric AdamMartine Jandrot-Perrus
Jan 15, 2004·Trends in Molecular Medicine·Karen VanhoorelbekeHans Deckmyn
Oct 31, 1988·Biochemical and Biophysical Research Communications·G J RothS A Williams
Aug 14, 2001·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·K J Clemetson
Jan 1, 1997·The International Journal of Biochemistry & Cell Biology·R K AndrewsM C Berndt
Oct 25, 1984·The New England Journal of Medicine·J N GeorgeD R Phillips
Jun 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R L NachmanB Ferris
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J A LopezG J Roth
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M J HickeyG J Roth
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J WareZ M Ruggeri
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·H R GralnickH Krutzsch
Jun 1, 1988·European Journal of Biochemistry·M Jandrot-PerrusA T Nurden
Sep 1, 1978·The Journal of Clinical Investigation·T J KunickiR H Aster
Feb 1, 1985·The Journal of Clinical Investigation·M S BrowerK Garry
Feb 1, 1986·The Journal of Clinical Investigation·J TakamatsuH R Gralnick
Apr 23, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Kenneth J Clemetson
Jan 1, 1983·Critical Reviews in Clinical Laboratory Sciences·M L Tiffany
Jan 1, 1990·Journal of Receptor Research·G I Karp, G Pinnamenneni
Jan 1, 1996·Progress in Histochemistry and Cytochemistry·H SuzukiK Tanoue
Dec 6, 2011·Thrombosis Research·Erica De Candia
Apr 1, 1987·Transfusion Medicine Reviews·J N George
Jun 11, 2005·Journal of Thrombosis and Haemostasis : JTH·N O Solum, K J Clemetson
Mar 15, 2008·Journal of Thrombosis and Haemostasis : JTH·J A GuerreroJ Ware
Jul 1, 1981·British Journal of Haematology·J N GeorgeD A Sears
Jan 1, 1986·Annals of the New York Academy of Sciences·M C BerndtP A Castaldi
Jan 1, 1986·Annals of the New York Academy of Sciences·J T Harmon, G A Jamieson
Jan 1, 1986·Annals of the New York Academy of Sciences·M A Shuman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.